Ikena Oncology, Inc., an oncology company, focuses on developing therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance. It develops IK-595, a molecular glue designed to trap MEK and RAF in an inactive complex. The company was incorporated in 2016 and is headquartered in Boston, Massachusetts. Show more

Location: 645 Summer Street, Boston, MA, 02210, United States | Website: https://ikenaoncology.com | Industry: Biotechnology | Sector: Healthcare


Market Cap

66.6M

52 Wk Range

$0.97 - $1.94

Previous Close

$1.38

Open

$1.41

Volume

173,778

Day Range

$1.33 - $1.43

Enterprise Value

-42.78M

Cash

114.1M

Avg Qtr Burn

-9.566M

Insider Ownership

8.00%

Institutional Own.

76.25%

Qtr Updated

03/31/25


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.